SCHEMBL7333315

SCHEMBL7333315

Nc1cccc2c1CCC(=O)C2

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.52
CD44 P16070 1/20 0.47
CYP1A2 P05177 2/20 0.43
PARP1 P09874 1/20 0.41
ALDH1A1 P00352 2/20 0.38
HPGD P15428 2/20 0.38
KDM4E B2RXH2 1/20 0.38
MEN1 O00255 1/20 0.38
LMNA P02545 1/20 0.38
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38
KMT2A Q03164 1/20 0.38
AKR1C3 P42330 1/20 0.33
CYP3A4 P08684 2/20 0.32
CYP2C9 P11712 1/20 0.32
CYP11B1 P15538 1/20 0.32
CYP11B2 P19099 1/20 0.32
CYP2C19 P33261 1/20 0.32
ANPEP P15144 2/20 0.32
AHR P35869 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10229515 0.86 CD44 (0.48) CYP2A6CD44CYP1A2PARP1ALDH1A1
SCHEMBL206466 0.84 CYP2A6 (0.52) CYP2A6CD44CYP1A2PARP1ALDH1A1
SCHEMBL9523617 0.83 CYP1A2 (0.52) CYP2A6CD44CYP1A2PARP1ALDH1A1
SCHEMBL20404268 0.78
SCHEMBL30060771 0.78
SCHEMBL1280654 0.78 CD44 (0.48) CYP2A6CD44CYP1A2ALDH1A1HPGD
SCHEMBL8061942 0.76 CYP2A6 (0.52) CYP2A6CYP1A2MEN1KMT2A
SCHEMBL266203 0.76 BCL2L1 (0.53) CYP2A6CYP1A2PARP1ALDH1A1MEN1
SCHEMBL14220348 0.76 CYP2A6 (0.52) CYP2A6CYP1A2ALDH1A1MEN1MAPT
SCHEMBL1662187 0.76 CYP2A6 (0.52) CYP2A6CYP1A2KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0402923-A2 2,5-Diaminotetralines, process for their preparation and their use as medicine BOEHRINGER INGELHEIM KG (DE) 1990-12-19 EP claimed
JP-3031244-A None JP disclosed
US-5196454-A METHOD OF TREATING DISORDERS OF THE DOPAMINERGIC SYSTEMS USING 2,5-DIAMINOTETRALINES BOEHRINGER INGELHEIM KG (DE) 1993-03-23 US disclosed
JP-H0331244-A NOVEL, 2,5-DIAMINOTETRALINE, ITS PRODUCTION AND ITS USE AS PHARMACEUTICAL COMPOSITION BOEHRINGER INGELHEIM KG 1991-02-12 JP disclosed
EP-0402923-A2 2,5-Diaminotetralines, process for their preparation and their use as medicine BOEHRINGER INGELHEIM KG (DE) 1990-12-19 EP disclosed